Filing Flows › Comparisons › COCP vs DWTX
Cocrystal Pharma vs Dogwood Therapeutics: COCP and DWTX compared
Cocrystal Pharma is the larger company: $105K of revenue in its latest quarter (Q2 2026) against $100K for Dogwood Therapeutics (Q3 2026).
Where the money goes: COCP and DWTX
Cocrystal Pharma (COCP) · Q2 2026
Cocrystal Pharma, Q2 2026: revenue $105K, net loss $3.2M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
Dogwood Therapeutics (DWTX) · Q3 2026
Dogwood Therapeutics, Q3 2026: revenue $100K, net loss $4.9M, operating cash flow −$4.6M. The chart follows the revenue to costs, profit and cash.
| Cocrystal Pharma (COCP) | Dogwood Therapeutics (DWTX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $105K | $100K |
| Operating margin | n/m | n/m |
| Net earnings | −$3.2M | −$4.9M |
| Operating cash flow | −$2.5M | −$4.6M |
Questions
Which is bigger, Cocrystal Pharma or Dogwood Therapeutics?
Cocrystal Pharma is the larger company: $105K of revenue in its latest quarter (Q2 2026) against $100K for Dogwood Therapeutics (Q3 2026).
More: Cocrystal Pharma earnings · how Cocrystal Pharma makes money · Dogwood Therapeutics earnings · how Dogwood Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.